Johnson & Johnson Says Profit Rises 12%
- Share via
Bloomberg News
Johnson & Johnson’s second-quarter profit rose 12% on increased sales of drugs to treat anemia and arthritis and devices used in heart procedures.
Net income rose to $1.65 billion, or 54 cents a share, from $1.48 billion, or 48 cents, a year earlier. Sales at the New Brunswick, N.J.-based company rose 11% to $9.07 billion.
Johnson & Johnson shares rose $1.10 to $50.10 on the New York Stock Exchange.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
